The 23-valent polysaccharide vaccine prevents pneumococcal pneumonia and reduces associated mortality in nursing home residents in Japan

Mark Loeb¹

Affiliations

Comment

Mark Loeb. Evid Based Med. 2010 Aug.

. 2010 Aug;15(4):117.

doi: 10.1136/ebm1077. Epub 2010 Jun 8.

Mark Loeb¹

¹ Michael G DeGroote Centre for Learning, McMaster University, West Hamilton, Ontario, Canada. loebm@mcmaster.ca

No abstract available

Comment on

Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial.
Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, D'Alessandro-Gabazza C, Nakayama S, Nishikubo K, Noguchi T, Takei Y, Gabazza EC. Maruyama T, et al. BMJ. 2010 Mar 8;340:c1004. doi: 10.1136/bmj.c1004. BMJ. 2010. PMID: 20211953 Free PMC article. Clinical Trial.